01 1Alembic Pharmaceuticals Limited
02 1Hetero Labs Limited
03 1MSN Laboratories Private Limited
04 1Sicor de Mexico S.A. de C.V
01 1AFATINIB DIMALEATE
02 3Afatinib Dimaleate
01 3India
02 1Mexico
NDC Package Code : 46708-895
Start Marketing Date : 2017-06-14
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 68554-0107
Start Marketing Date : 2013-07-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54893-0054
Start Marketing Date : 2016-12-31
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63592-0355
Start Marketing Date : 2015-11-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
A Afatinib (diMaleate) manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Afatinib (diMaleate), including repackagers and relabelers. The FDA regulates Afatinib (diMaleate) manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Afatinib (diMaleate) API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Afatinib (diMaleate) manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Afatinib (diMaleate) supplier is an individual or a company that provides Afatinib (diMaleate) active pharmaceutical ingredient (API) or Afatinib (diMaleate) finished formulations upon request. The Afatinib (diMaleate) suppliers may include Afatinib (diMaleate) API manufacturers, exporters, distributors and traders.
click here to find a list of Afatinib (diMaleate) suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Afatinib (diMaleate) as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Afatinib (diMaleate) API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Afatinib (diMaleate) as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Afatinib (diMaleate) and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Afatinib (diMaleate) NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Afatinib (diMaleate) suppliers with NDC on PharmaCompass.
We have 4 companies offering Afatinib (diMaleate)
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
